64544-24-7 Usage
Uses
Used in Pharmaceutical Industry:
4-chloro-N-[2-(4-oxidomorpholin-4-yl)ethyl]benzamide is used as a pharmaceutical intermediate for the synthesis of various drugs. Its specific structural features allow it to serve as a building block in the development of new medications with potential therapeutic benefits.
Used in Chemical Research:
In the field of chemical research, 4-chloro-N-[2-(4-oxidomorpholin-4-yl)ethyl]benzamide can be utilized as a starting material or a reactant in the synthesis of more complex organic compounds. Its unique functional groups enable it to participate in various chemical reactions, contributing to the advancement of organic chemistry.
Used in Material Science:
4-chloro-N-[2-(4-oxidomorpholin-4-yl)ethyl]benzamide may also find applications in material science, particularly in the development of new polymers or other materials with specific properties. Its chemical structure can be tailored to create materials with desired characteristics, such as improved stability, solubility, or reactivity.
Check Digit Verification of cas no
The CAS Registry Mumber 64544-24-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,4,5,4 and 4 respectively; the second part has 2 digits, 2 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 64544-24:
(7*6)+(6*4)+(5*5)+(4*4)+(3*4)+(2*2)+(1*4)=127
127 % 10 = 7
So 64544-24-7 is a valid CAS Registry Number.
64544-24-7Relevant academic research and scientific papers
Hanlon, Steven P.,Camattari, Andrea,Abad, Sandra,Glieder, Anton,Kittelmann, Matthias,Luetz, Stephan,Wirz, Beat,Winkler, Margit
, p. 6001 - 6003 (2012)
A panel of human flavin monooxygenases were heterologously expressed in E. coli to obtain ready-to-use biocatalysts for the in vitro preparation of human drug metabolites. Moclobemide-N-oxide (65 mg) was the first high-priced metabolite prepared with recombinant hFMO3 on the multi-milligram scale.
Hoskins,Shenfield,Murray,Gross
, p. 387 - 397 (2001)
1. Moclobemide undergoes morpholine ring N-oxidation to form a major metabolite in plasma, Ro12-5637. 2. The kinetics of moclobemide N-oxidation in human liver microsomes (HLM) (n = 6) have been investigated and the mixed-function oxidase enzymes catalysi
